BackImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies Profit Margin

Profitability ratio analysis for IPA.

Quarterly Profit Margin

-94.52%
↑ 72.99% YoY

As of Jan 2026

Annual Profit Margin (TTM)

-66.38%
↑ 65.46% YoY

Trailing 12 months ending Jan 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin